mhurhangee/ep-ind-claims huggingface dataset:
A garment (100; 800) comprising: a first zone (136, 146; 740; 840, 860) comprising a first material formed from yarns having a first denier per filament; and a second zone (134, 144; 730; 830, 850) adjacent the first zone (136, 146; 740; 840, 860), the second zone (134, 144; 730; 830, 850) comprising a second material formed from yarns making up a wipe zone (134, 144; 730; 830, 850) and the yarns having a second DPF, wherein the second DPF is within a range of 0.025 to 0.0025; and wherein the second material is hydrophobic. a first zone (136, 146; 740; 840, 860) comprising a first material formed from yarns having a first denier per filament; and a second zone (134, 144; 730; 830, 850) adjacent the first zone (136, 146; 740; 840, 860), the second zone (134, 144; 730; 830, 850) comprising a second material formed from yarns making up a wipe zone (134, 144; 730; 830, 850) and the yarns having a second DPF, wherein the second DPF is within a range of 0.025 to 0.0025; and wherein the second material is hydrophobic.
Apparatus for a neuromodulation system (210; 520; 624; 1711-1713), comprising: neuromodulation generator circuitry (212; 312; 512; 626; 726; 1776) configured to use electrodes (211; 311; 511; 631; 725; 1044; 1145; 1711) of an electrode arrangement to generate neuromodulation fields including: a therapeutic neuromodulation field to produce a therapeutic effect in therapy-targeted neural tissue; and a priming field to produce a priming effect in priming-targeted neural tissue, wherein the priming effect causes a change in sensitization of the priming-targeted neural tissue to the therapeutic neuromodulation field; and a controller (213; 413; 522; 1712, 1713) configured to execute a set of startup operations of the neuromodulation system, the set of startup operations including in-situ electrical measurements to determine a type of electrode arrangement, and to cause the neuromodulation generator circuitry (212; 312; 512; 626; 726; 1776) to initiate the priming field in response to completion of the set of startup operations. neuromodulation generator circuitry (212; 312; 512; 626; 726; 1776) configured to use electrodes (211; 311; 511; 631; 725; 1044; 1145; 1711) of an electrode arrangement to generate neuromodulation fields including: a therapeutic neuromodulation field to produce a therapeutic effect in therapy-targeted neural tissue; and a priming field to produce a priming effect in priming-targeted neural tissue, wherein the priming effect causes a change in sensitization of the priming-targeted neural tissue to the therapeutic neuromodulation field; and a therapeutic neuromodulation field to produce a therapeutic effect in therapy-targeted neural tissue; and a priming field to produce a priming effect in priming-targeted neural tissue, wherein the priming effect causes a change in sensitization of the priming-targeted neural tissue to the therapeutic neuromodulation field; and a controller (213; 413; 522; 1712, 1713) configured to execute a set of startup operations of the neuromodulation system, the set of startup operations including in-situ electrical measurements to determine a type of electrode arrangement, and to cause the neuromodulation generator circuitry (212; 312; 512; 626; 726; 1776) to initiate the priming field in response to completion of the set of startup operations.
A method for the detection of a severe acute respiratory syndrome (SARS)-associated coronavirus infection in a biological sample comprising: - providing a severe acute respiratory syndrome-associated coronavirus 2 (SARS-CoV-2) nucleocapsid protein expressed and purified from E. coli strain BL21 pDIA17 transformed with recombinant plasmid pETM11/N-nCov E. coli 3 -(His)6-Nter or pETM11/N-nCov E. coli 4 -(His)6-Nter deposited at the Collection Nationale de Cultures de Microorganismes (CNCM) at the Institut Pasteur, 25, Rue du Docteur Roux, 75724 Paris, FR, on May 11, 2020, under the deposit numbers CNCM I-5510 and CNCM I-5511, respectively; - providing a biological sample from an individual or a patient suspected to be infected with a severe acute respiratory syndrome-associated coronavirus (SARS-CoV); - contacting said SARS-CoV-2 N protein with said biological sample; and - visualizing the antigen-antibody complexes formed. - providing a severe acute respiratory syndrome-associated coronavirus 2 (SARS-CoV-2) nucleocapsid protein expressed and purified from E. coli strain BL21 pDIA17 transformed with recombinant plasmid pETM11/N-nCov E. coli 3 -(His)6-Nter or pETM11/N-nCov E. coli 4 -(His)6-Nter deposited at the Collection Nationale de Cultures de Microorganismes (CNCM) at the Institut Pasteur, 25, Rue du Docteur Roux, 75724 Paris, FR, on May 11, 2020, under the deposit numbers CNCM I-5510 and CNCM I-5511, respectively; - providing a biological sample from an individual or a patient suspected to be infected with a severe acute respiratory syndrome-associated coronavirus (SARS-CoV); - contacting said SARS-CoV-2 N protein with said biological sample; and - visualizing the antigen-antibody complexes formed.
A computer-implemented method (100, 200) for detecting a known pattern having homogenous areas (10a, 10b) as calibration target for a camera calibration, the method (100, 200) comprising the steps: taking an image of at least a portion of the known pattern; initially detecting a first region of the image, the first region comprising at least two homogenous areas (10a, 10b), to estimate at least one region parameter for the first region; the at least one region parameter comprising the position of the region, detecting a feature of the known pattern within a second region of the image, the second region comprising at least two homogenous areas (10a, 10b) and being adjacent to the first region, to obtain at least one region parameter of the feature within the second region; wherein the step of detecting the feature is iterated for a third region of the image, the third region comprising at least two homogenous areas (10a, 10b) and being adjacent to the first and/or the second region to obtain at least one region parameter for the feature within the third region; wherein the step of detecting a feature of the known pattern is iterated for another region in a direction extending from the first region and going through the second region and/or third region taking into account an adapted projection model until no additional feature is found in this direction. taking an image of at least a portion of the known pattern; initially detecting a first region of the image, the first region comprising at least two homogenous areas (10a, 10b), to estimate at least one region parameter for the first region; the at least one region parameter comprising the position of the region, detecting a feature of the known pattern within a second region of the image, the second region comprising at least two homogenous areas (10a, 10b) and being adjacent to the first region, to obtain at least one region parameter of the feature within the second region; wherein the step of detecting the feature is iterated for a third region of the image, the third region comprising at least two homogenous areas (10a, 10b) and being adjacent to the first and/or the second region to obtain at least one region parameter for the feature within the third region; wherein the step of detecting a feature of the known pattern is iterated for another region in a direction extending from the first region and going through the second region and/or third region taking into account an adapted projection model until no additional feature is found in this direction.
An impedance matching device with an impedance matching network (200, 400, 600), comprising: an input terminal (206, 406, 606) configured to receive a radio frequency signal; an output terminal (208, 408, 608) configured to couple to an amplifier; an impedance prematch network (202, 402) coupled to the input terminal (206, 406, 606) and the output terminal (208, 408, 608), the impedance prematch network (202, 402) including a first inductive element (212, 412, 612); and a resonator structure (204, 404, 602, 604) including a second inductive element (230, 430, 618) inductively coupled to the first inductive element (212, 412, 612), characterized in that the first inductive element (212, 412, 612) is a first wire bond (412, 612) and the second inductive element (230, 430, 618) is a second wire bond (430, 618), and the impedance prematch network (202, 402) and the resonator structure (204, 404, 602, 604) are connected only by the inductive coupling of the first wire bond (412, 612) and the second wire bond (430, 618). an input terminal (206, 406, 606) configured to receive a radio frequency signal; an output terminal (208, 408, 608) configured to couple to an amplifier; an impedance prematch network (202, 402) coupled to the input terminal (206, 406, 606) and the output terminal (208, 408, 608), the impedance prematch network (202, 402) including a first inductive element (212, 412, 612); and a resonator structure (204, 404, 602, 604) including a second inductive element (230, 430, 618) inductively coupled to the first inductive element (212, 412, 612), characterized in that the first inductive element (212, 412, 612) is a first wire bond (412, 612) and the second inductive element (230, 430, 618) is a second wire bond (430, 618), and the impedance prematch network (202, 402) and the resonator structure (204, 404, 602, 604) are connected only by the inductive coupling of the first wire bond (412, 612) and the second wire bond (430, 618).
Apparatus for working elongated blanks, such as tubes, bars, sections and strips, comprising a plurality of machines (10, 12, 14) arranged in line along a longitudinal direction (x) coinciding with a feed direction of the blank, each of said machines (10, 12, 14) comprising at least one working member (18, 20, 22), which is rotatably mounted about an axis of rotation (z1, z2, z3) and is adapted to work on the blank so as to apply on it a force having a component directed along the longitudinal direction (x), motor means for driving said at least one working member (18, 20, 22) into rotation, and a control unit for controlling said motor means, characterized in that each machine (10, 12, 14) is provided with measuring means for providing the control unit of said machine with a measure of the overall reaction exerted in operation by the blank on said machine along the longitudinal direction (x) and in that the control unit of each machine (10, 12, 14) is arranged to control said motor means in such a manner that the value, provided by said measuring means, of the overall reaction exerted in operation by the blank on said machine along the longitudinal direction (x) is equal to a predetermined value, zero included.
Nuclear magnetic resonance imaging method in which, with the aid of a gradient system, there is generated a spatially and temporally variable magnetic field B grad for the at least two-dimensional spatial encoding of NMR measurement signals in a measurement sample region to be imaged, where, during a single measurement cycle from excitation to reading of the NMR measurement signals, the magnetic field B grad is employed for the reconstruction of an MR image in at least two substantially concentric, spatial forms B grad 1 (SEM C) and B grad 2 (SEM IC) in the measurement sample region to be imaged for the at least two-dimensional spatial encoding, where the at least two forms B grad 1 and B grad 2 in the region to be imaged are each a non-bijectively spatially variable magnetic field (NBSEM), where the first form B grad 1 (SEM C) has ns poles, where ns is an even number > 2, and has ns essentially sectorial sub-regions, in each of which the magnetic field B grad is locally monotonic in one direction, where the measurement signals from the measurement sample are recorded by means of at least ns receiver coils (61 a, 61 b) which have different sensitivity over the ns sub-regions of the region to be imaged such that by means of parallel reconstruction methods, the complete MR image of the region to be imaged can be obtained from the measurement signals of the ns receiver coils, characterized in that the second spatial form B grad 2 (SEM C) is identical to the first spatial form B grad 1 (SEM C) except for the following defined rotation, with the second form B grad 2 (SEM IC) being rotated by an angle Δφ, where Δ φ = 360 ° 2 ⋅ ns, relative to the first form B grad 1 (SEMc).
A sealing wafer adapted to be arranged in a stoma receiving hole of a base plate comprising an attachment platform extending from an outer periphery adapted to be attached to the base plate towards an inner periphery defining a through-going hole for receiving a stoma, the sealing wafer further comprises at least a first urging part extending transversely from the proximal surface facing towards the user during use of the attachment platform, wherein the first urging part is resilient in the direction transverse to the proximal surface, characterised in that the first urging part is formed of a sheet folded with alternating folds.
A reduced-pressure delivery system for percutaneous delivery of reduced pressure to a tissue site, the delivery system comprising: a reduced-pressure manifold formed from a first material having a first bio-absorption term (BA 1) and a second material having second bio-absorption term (BA 2), the reduced-pressure manifold having an insertion position and an activation position; wherein the reduced-pressure manifold is substantially planar in the activation position; a reduced-pressure delivery member having a distal end with at least one delivery aperture for delivering reduced pressure to the tissue site; an insertion device for percutaneously delivering the reduced-pressure manifold and the distal end of the reduced-pressure delivery tube to the tissue site and transitioning the reduced-pressure manifold from the insertion position to the activation position; and wherein the first bio-absorption term is greater than the second bio-absorption term (BA 1 > BA 2) so that a first plurality of apertures are formed when the second material is absorbed. a reduced-pressure manifold formed from a first material having a first bio-absorption term (BA 1) and a second material having second bio-absorption term (BA 2), the reduced-pressure manifold having an insertion position and an activation position; wherein the reduced-pressure manifold is substantially planar in the activation position; a reduced-pressure delivery member having a distal end with at least one delivery aperture for delivering reduced pressure to the tissue site; an insertion device for percutaneously delivering the reduced-pressure manifold and the distal end of the reduced-pressure delivery tube to the tissue site and transitioning the reduced-pressure manifold from the insertion position to the activation position; and wherein the first bio-absorption term is greater than the second bio-absorption term (BA 1 > BA 2) so that a first plurality of apertures are formed when the second material is absorbed.
A transmucosal film dosage form comprising by weight: 2-20 % a dopamine agonist selected from D 1 dopamine agonists, D 2 dopamine agonists and combinations of a D 1 dopamine agonist and a D 2 dopamine agonist, 0.5-10 % film forming agent, 2-20 % stabilizing enhancer, 20-95 % bioadhesion enhancers, 3.8-45 % cyclodextrin, and optionally 1-5 % oleic acid. 2-20 % a dopamine agonist selected from D 1 dopamine agonists, D 2 dopamine agonists and combinations of a D 1 dopamine agonist and a D 2 dopamine agonist, 0.5-10 % film forming agent, 2-20 % stabilizing enhancer, 20-95 % bioadhesion enhancers, 3.8-45 % cyclodextrin, and
Method for determining an estimated value ( ŜNR ( n)) for a signal-to-noise ratio of a non-linearly phase-modulated or frequency-modulated received signal ( r FM ( t)) which is dependent on a transmitted signal ( s FM ( t)) and a noise signal ( z k ( t)), by iterative maximum likelihood estimation of an estimated value ( Ŝ ( n)) for the squared fading amplitude, of an estimated value ( N̂ 0 ( n)) for the noise power ( N 0) of the noise signal ( z k ( t)) and conditional probabilities ( p k,m ( n)) for the matching of each data symbol ( d ( k)) modulated in a point in time k in the transmitted signal ( s FM ( t)) with each data symbol ( α ( m)) of the symbol alphabet used, until an estimated value ( ŜNR ( n)) for the signal-to-noise ratio calculated as the quotient of the estimated value ( Ŝ ( n)) for the squared fading amplitude and the estimated value ( N̂ 0 ( n)) for the noise power ( N 0) of the noise signal ( z k ( t)) corresponds to a defined convergence criterion, characterised in that the estimated value ( S ( n)) for the squared fading amplitude and the estimated value ( N̂ 0 ( n)) for the noise power ( N 0) of the noise signal ( z k ( t)) are determined in an iteration step n by means of maximisation of a probability density function f ( Y |Φ) of output signals ( y 0,.., y k,.., y K -1) of M matched filters (2 0,2 1,...,2 M-1) which each filter the non-linearly phase-modulated or frequency-modulated received signal ( r FM ( t)), and a quotient (Ψ( x)) of a modified Bessel function of 1st genus and 1st order ( I 1 ( x)) and a modified Bessel function of 1st genus and Oth order ( I 0 ( x)) appearing during the maximisation of the probability density function f ( Y |Φ) is replaced by an approximate term 1 − a x, in which a is an adjustable matching factor and x is an argument of the two Bessel functions ( I 0 ( x), I 1 ( x)).
An assembly for folding polymeric film for machines for forming pouches and the like of the type comprising a fixed frame for supporting a magazine for said polymeric film, an element for folding the film that arrives from said magazine and at least one heat-sealing device for the stable coupling of juxtaposed portions of said folded film that arrives from said folding element, characterized in that said folding element is mounted on a carriage, which can translate along a respective guide which is integral with said frame, along the sliding direction of said film, with a speed that is variable in intensity and sign, said at least one heat-sealing device acting on portions folded onto themselves of said film during a temporary stop thereof, said carriage retracting with respect to said sliding direction of said film for the entire duration of the temporary stop step provided for the heat-sealing of the film.
Method for manufacturing a bearing (1, 11) including the following steps: a) forming a ceramic precursor from a ceramic-based powder bound in a binder; b) compressing, using an upper die (23, 25, 35, 37, 38, 39) and a lower die (23, 25, 35, 27, 38, 39), the ceramic precursor so as to form a green body of the future bearing (1, 11) with top and bottom surfaces including respectively first and second functional elements (28, 30) leaving a thickness (i) of material between said first and second functional elements; c) sintering the green body so as to form a ceramic body; d) forming a through hole in the body so as to connect said first and second functional elements. a) forming a ceramic precursor from a ceramic-based powder bound in a binder; b) compressing, using an upper die (23, 25, 35, 37, 38, 39) and a lower die (23, 25, 35, 27, 38, 39), the ceramic precursor so as to form a green body of the future bearing (1, 11) with top and bottom surfaces including respectively first and second functional elements (28, 30) leaving a thickness (i) of material between said first and second functional elements; c) sintering the green body so as to form a ceramic body; d) forming a through hole in the body so as to connect said first and second functional elements.
A process for preparing a Mn 4+ doped phosphor of formula I, A x [MF y]:Mn +4 I the process comprising combining an A + cation, an anion of formula MF y, and a Mn n+ source comprising a fluoromanganese compound in an acidic solution; precipitating a Mn n+ containing phosphor precursor from the acidic solution; and contacting the Mn n+ containing phosphor precursor with a fluorine-containing oxidizing agent in gaseous form, at an elevated temperature, to form the Mn 4+ doped phosphor; wherein A is Li, Na, K, Rb, Cs, or a combination thereof; M is Si, Ge, Sn, Ti, Zr, Al, Ga, In, Sc, Hf, Y, La, Nb, Ta, Bi, Gd, or a combination thereof; x is the absolute value of the charge of the [MF y] ion; y is 5, 6 or 7; and n is 2 or 3. the process comprising combining an A + cation, an anion of formula MF y, and a Mn n+ source comprising a fluoromanganese compound in an acidic solution; precipitating a Mn n+ containing phosphor precursor from the acidic solution; and contacting the Mn n+ containing phosphor precursor with a fluorine-containing oxidizing agent in gaseous form, at an elevated temperature, to form the Mn 4+ doped phosphor; wherein A is Li, Na, K, Rb, Cs, or a combination thereof; M is Si, Ge, Sn, Ti, Zr, Al, Ga, In, Sc, Hf, Y, La, Nb, Ta, Bi, Gd, or a combination thereof; x is the absolute value of the charge of the [MF y] ion; y is 5, 6 or 7; and n is 2 or 3.
A method for labeling a prostate-specific membrane antigen (PSMA) ligand with a radioactive isotope selected from 68 Ga, 177 Lu, or 90 Y, said method comprising the steps of: (i) providing a reaction vial containing a predetermined amounts of a sodium-based buffering agent and said PSMA ligand, both in dried form; (ii) adding a solution of said radioactive isotope in a predetermined amount of HCl having a predetermined molarity to said reaction vial, thus obtaining a solution of said PSMA ligand and said radioactive isotope in said HCl; (iii) mixing the solution obtained in (ii) and then incubating it for a sufficient period of time, thus reacting said PSMA ligand with said radioactive isotope to thereby obtain said PSMA ligand labeled with said radioactive isotope, wherein at least 90% of said radioactive isotope in said solution is bound to said PSMA ligand; and (iv) optionally adjusting the pH of the solution in said reaction vial to a pH compatible with physiological conditions by adding a sodium-based buffering agent, wherein said PSMA ligand is of the general formula I: I R 1 -CO-R 2 -L-B-X wherein B is a chelating agent capable of coordinating with said radioactive isotope; X is absent or is of the formula -L'-R 2 '-CO- R 1 '; L and L' each independently is absent or a linker; R 1 and R 1 ', if present, each is a glutamic acid residue linked via the amino group thereof to the adjacent -CO- group; and R 2 and R 2 ', if present, each is a glutamic acid residue or a lysine residue linked via an amino group thereof to the adjacent -CO- group. (i) providing a reaction vial containing a predetermined amounts of a sodium-based buffering agent and said PSMA ligand, both in dried form; (ii) adding a solution of said radioactive isotope in a predetermined amount of HCl having a predetermined molarity to said reaction vial, thus obtaining a solution of said PSMA ligand and said radioactive isotope in said HCl; (iii) mixing the solution obtained in (ii) and then incubating it for a sufficient period of time, thus reacting said PSMA ligand with said radioactive isotope to thereby obtain said PSMA ligand labeled with said radioactive isotope, wherein at least 90% of said radioactive isotope in said solution is bound to said PSMA ligand; and (iv) optionally adjusting the pH of the solution in said reaction vial to a pH compatible with physiological conditions by adding a sodium-based buffering agent, B is a chelating agent capable of coordinating with said radioactive isotope; X is absent or is of the formula -L'-R 2 '-CO- R 1 '; L and L' each independently is absent or a linker; R 1 and R 1 ', if present, each is a glutamic acid residue linked via the amino group thereof to the adjacent -CO- group; and R 2 and R 2 ', if present, each is a glutamic acid residue or a lysine residue linked via an amino group thereof to the adjacent -CO- group.